Guidelines for Hypertension in the 1999 Revised Version-Elderly
暂无分享,去创建一个
T. Ogihara | M. Fujishima | K. Shimamoto | K. Kohara | Y. Kawano | H. Matsuoka | S. Takishita | H. Mikami | M. Eto | K. Toba | K. Hiwada | I. Abe | S. Morimoto | K. Iwai | M. Matsumoto | K. Higashiura | M. Takasaki | Koichi Kozaki
[1] Y. Kuriyama,et al. Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension , 2005, European Journal of Clinical Pharmacology.
[2] O. Paulson,et al. Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers , 2004, European Journal of Clinical Pharmacology.
[3] K. Kern,et al. Digoxin-diltiazem interaction: A pharmacokinetic evaluation , 2004, European Journal of Clinical Pharmacology.
[4] M. Kinoshita,et al. [J-curve phenomenon]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.
[5] P. Verdecchia. Prognostic Value of Ambulatory Blood Pressure , 2000 .
[6] ICHAEL,et al. THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .
[7] S. Kaul,et al. Writing Group Members , 2022 .
[8] Bruce Neal,et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.
[9] J A Staessen,et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.
[10] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[11] J. Webster,et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. , 1998, Archives of internal medicine.
[12] Y. Kawano,et al. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. , 1998, Hypertension.
[13] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[14] M. Moser,et al. Why are physicians not prescribing diuretics more frequently in the management of hypertension? , 1998, JAMA.
[15] P. Whelton,et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.
[16] I. Wiklund,et al. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. , 1997, Blood pressure.
[17] T. Ogihara,et al. [Evaluation by specialists of the Guidelines on Treatment of Hypertension in the Elderly--the second questionnaire survey]. , 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[18] T. Strandberg,et al. Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. , 1997, European heart journal.
[19] J. Bagger,et al. Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment. , 1997, Circulation.
[20] S. Ibayashi,et al. Amlodipine, a Ca2+ channel antagonist, modifies cerebral blood flow autoregulation in hypertensive rats. , 1996, European journal of pharmacology.
[21] O. Iimura. Insulin resistance and hypertension in Japanese. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.
[22] Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.
[23] D. Phillips,et al. Accuracy of automated finger blood pressure devices. , 1996, Family medicine.
[24] M. Olsen,et al. Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension. , 1996, Journal of human hypertension.
[25] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[26] K. Kario,et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. , 1996, Hypertension.
[27] S. Ibayashi,et al. Cerebral Blood Flow and Metabolism in Hypertensive Patients with Cerebral Infarction , 1995, Angiology.
[28] B. Psaty,et al. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. , 1995, Circulation.
[29] R. Glynn,et al. HDL cholesterol predicts coronary heart disease mortality in older persons. , 1995, JAMA.
[30] M. O'Rourke,et al. Mechanical principles in arterial disease. , 1995, Hypertension.
[31] M. Quiñones,et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. , 1995, Circulation.
[32] R. Herings,et al. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme , 1995, The Lancet.
[33] G. Reboldi,et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.
[34] F. Veith,et al. Peripheral Vascular Disease in the Elderly. , 1994, The American journal of geriatric cardiology.
[35] R. O. Day,et al. NSAID-related adverse drug interactions with clinical relevance. An update. , 1994, International journal of clinical pharmacology and therapeutics.
[36] J. Grotta,et al. Guidelines for the Management of Patients With Acute Ischemic Stroke A Statement for Healthcare Professionals , 2005 .
[37] S. Ibayashi,et al. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats. , 1994, Hypertension.
[38] T. Ogihara,et al. [Therapeutic policy for elderly hypertensives in Japan--a questionnaire survey of specialists]. , 1994, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[39] Lippincott Williams Wilkins,et al. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly , 1994, Hypertension.
[40] W. L. Ooi,et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. , 1994, Hypertension.
[41] T. Chalmers,et al. Drug treatment of hypertension in the elderly: a meta-analysis. , 1994, Annals of internal medicine.
[42] Yutaka Imai,et al. Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan , 1993, Journal of hypertension.
[43] Y. Imai,et al. Ambulatory blood pressure of adults in Ohasama, Japan. , 1993, Hypertension.
[44] K. Minematsu,et al. The J‐Curve Phenomenon in Stroke Recurrence , 1993, Stroke.
[45] Lawrence A Leiter,et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[46] Giuseppe Mancia,et al. 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting , 1993 .
[47] P Barham,et al. Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.
[48] C. Bulpitt,et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.
[49] Y Chen,et al. Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.
[50] B. Kasiske,et al. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.
[51] Y. Goriya,et al. Effect of ageing on the relationship between early diastolic left ventricular function and mitral valve motion. , 1993, The Canadian journal of cardiology.
[52] M. E. Kitler. Elderly hypertensives and quality of life: some methodological considerations. , 1993, European heart journal.
[53] The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.
[54] K. Shimada,et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. , 1992, Journal of hypertension.
[55] C. Dollery,et al. Medical Research Council trial of treatment of hypertension in older adults: principal results. , 1992 .
[56] C. Berne,et al. Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors , 1991, Diabetes Care.
[57] F. Mee,et al. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. , 1991, Journal of hypertension.
[58] D. Bailey,et al. Interaction of citrus juices with felodipine and nifedipine , 1991, The Lancet.
[59] N. Hertzer. The Natural History of Peripheral Vascular Disease: Implications for Its Management , 1991, Circulation.
[60] C. Mulrow,et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? , 1991, JAMA.
[61] Na Na. Physical exercise in the management of hypertension: a consensus statement by the World Hypertension League. , 1991, Journal of hypertension.
[63] K. Shimada,et al. Silent Cerebrovascular Disease in the Elderly Correlation With Ambulatory Pressure , 1990, Hypertension.
[64] R. Venuto,et al. Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[65] I. Kuwajima,et al. Pseudohypertension in the elderly. , 1990, Journal of hypertension.
[66] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[67] A. Kanto,et al. Blood pressure in the very old. , 1990, Journal of hypertension.
[68] K. Shimada,et al. Noninvasive ambulatory blood pressure monitoring during clinic visit in elderly hypertensive patients. , 1990, Clinical and experimental hypertension. Part A, Theory and practice.
[69] M. Frank,et al. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. , 1990, Journal of the American College of Cardiology.
[70] R S Paffenbarger,et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. , 1989, JAMA.
[71] C. Bulpitt,et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. , 1989, BMJ.
[72] W. Applegate. Hypertension in elderly patients. , 1989, Annals of internal medicine.
[73] W. T. Davies,et al. Nifedipine in patients with peripheral vascular disease. , 1989, European journal of vascular surgery.
[74] G. Tsujimoto,et al. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1. , 1989, International journal of clinical pharmacology, therapy, and toxicology.
[75] J. Kostis,et al. The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[76] R. Bonow,et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. , 1988, The New England journal of medicine.
[77] D. Bernardi,et al. Assessment of Captopril and Nicardipine Effects on Chronic Occlusive Arterial Disease of the Lower Extremity Using Doppler Ultrasound , 1988, Angiology.
[78] M. Tuck. Management of hypertension in the patient with diabetes mellitus. Focus on the use of angiotensin-converting enzyme inhibitors. , 1988, American journal of hypertension.
[79] G. Scally. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. , 1988, BMJ.
[80] Y. Imai,et al. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. , 1988, Hypertension.
[81] C. Bulpitt,et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1988, Journal of human hypertension.
[82] Matti Haavisto,et al. Blood pressure and five year survival in the very old , 1988, British medical journal.
[83] J. Laragh,et al. How common is white coat hypertension? , 1988, JAMA.
[84] V. Vertes. Weight reduction for control of systemic hypertension. , 1987, The American journal of cardiology.
[85] A. Breckenridge,et al. PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION , 1987, The Lancet.
[86] K. Pennert,et al. Low Mortality from All Causes, Including Myocardial Infarction, in Well‐Controlled Hypertensives Treated with a Beta‐Blocker Plus Other Antihypertensives , 1987, Journal of hypertension.
[87] J. Cruickshank,et al. BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE , 1987, The Lancet.
[88] G Parati,et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.
[89] D. Reed,et al. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. , 1987, The American journal of clinical nutrition.
[90] E. Barrett-Connor,et al. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. , 1987, The New England journal of medicine.
[91] J. Cleland,et al. The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure. , 1986, American heart journal.
[92] F. Messerli. Osler's maneuver, pseudohypertension, and true hypertension in the elderly. , 1986, American Journal of Medicine.
[93] S. Matsushita,et al. The treatment of mild hypertension in the elderly, a prospective study using multiple regression analysis. , 1985, Japanese circulation journal.
[94] D. Salant,et al. Anuric renal failure precipitated by indomethacin and triamterene. , 1985, Nephron.
[95] N. Shock,et al. Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.
[96] D. Pennell,et al. FATAL STEVENS-JOHNSON SYNDROME IN A PATIENT ON CAPTOPRIL AND ALLOPURINOL , 1984, The Lancet.
[97] J. Stanton,et al. Blood pressure and nutrient intake in the United States. , 1984, Science.
[98] FRCP W. J. MacLennan MD,et al. The Elderly , 1984, Treatment in Clinical Medicine.
[99] T. Wilson,et al. Amantadine-dyazide interaction. , 1983, Canadian Medical Association journal.
[100] E B Raftery,et al. Circadian variation of blood pressure in autonomic failure. , 1983, Circulation.
[101] W. Kirch,et al. Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine. , 1983, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[102] L. Symon,et al. The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. , 1982, Stroke.
[103] J. Drayer,et al. Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age. , 1982, The American journal of medicine.
[104] D. Hunninghake,et al. The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide. , 1982, International journal of clinical pharmacology, therapy, and toxicology.
[105] W. Kirch,et al. Interaction of atenolol with furosemide and calcium and aluminum salts , 1981, Clinical pharmacology and therapeutics.
[106] T. Kawasaki,et al. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. , 1978, The American journal of medicine.
[107] W. Kannel. Role of blood pressure in cardiovascular morbidity and mortality. , 1974, Progress in cardiovascular diseases.
[108] O B Paulson,et al. Regional cerebral blood flow in apoplexy without arterial occlusion , 1970, Neurology.
[109] M. Arisawa,et al. [Renal vascular hypertension]. , 1967, Ganka. Ophthalmology.
[110] D F DAVIES,et al. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. , 1950, The Journal of clinical investigation.